Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 1
1991 3
1992 3
1993 6
1994 4
1995 1
1996 5
1997 2
1998 2
1999 1
2000 5
2001 1
2002 2
2003 2
2004 2
2005 5
2006 1
2008 4
2009 2
2010 2
2011 1
2014 1
2015 4
2016 2
2017 2
2018 2
2019 6
2020 6
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Bring on the Biosimilars!
Avalos BR. Avalos BR. Biol Blood Marrow Transplant. 2015 Nov;21(11):1859-60. doi: 10.1016/j.bbmt.2015.09.010. Epub 2015 Sep 18. Biol Blood Marrow Transplant. 2015. PMID: 26386317 Free article. No abstract available.
Can G-CSF cause leukemia in hematopoietic stem cell donors?
Avalos BR, Lazaryan A, Copelan EA. Avalos BR, et al. Biol Blood Marrow Transplant. 2011 Dec;17(12):1739-46. doi: 10.1016/j.bbmt.2011.07.003. Epub 2011 Jul 13. Biol Blood Marrow Transplant. 2011. PMID: 21745453 Free article. Review.
Survival following allogeneic transplant in patients with myelofibrosis.
Gowin K, Ballen K, Ahn KW, Hu ZH, Ali H, Arcasoy MO, Devlin R, Coakley M, Gerds AT, Green M, Gupta V, Hobbs G, Jain T, Kandarpa M, Komrokji R, Kuykendall AT, Luber K, Masarova L, Michaelis LC, Patches S, Pariser AC, Rampal R, Stein B, Talpaz M, Verstovsek S, Wadleigh M, Agrawal V, Aljurf M, Angel Diaz M, Avalos BR, Bacher U, Bashey A, Beitinjaneh AM, Cerny J, Chhabra S, Copelan E, Cutler CS, DeFilipp Z, Gadalla SM, Ganguly S, Grunwald MR, Hashmi SK, Kharfan-Dabaja MA, Kindwall-Keller T, Kröger N, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Nathan S, Nishihori T, Olsson RF, Pawarode A, Rowe JM, Savani BN, Savoie ML, Seo S, Solh M, Tamari R, Verdonck LF, Yared JA, Alyea E, Popat U, Sobecks R, Scott BL, Nakamura R, Mesa R, Saber W. Gowin K, et al. Among authors: avalos br. Blood Adv. 2020 May 12;4(9):1965-1973. doi: 10.1182/bloodadvances.2019001084. Blood Adv. 2020. PMID: 32384540 Free PMC article.
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax.
Chojecki AL, Arnall J, Boselli D, Patel R, Chiad Z, DiSogra KY, Karabinos A, Chen T, Cruz A, Verbyla A, Ai J, Knight TG, Ragon BK, Shah NA, Sanikommu SR, Symanowski J, Avalos BR, Copelan EA, Grunwald MR. Chojecki AL, et al. Among authors: avalos br. Leuk Res. 2022 Aug;119:106904. doi: 10.1016/j.leukres.2022.106904. Epub 2022 Jun 21. Leuk Res. 2022. PMID: 35753088 No abstract available.
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF).
Chojecki AL, DiSogra KY, Arnall J, Cowgill N, Soni A, Packman CH, Sanikommu SR, Shah NA, Ragon BK, Knight TG, Ai J, Avalos BR, Copelan EA, Grunwald MR. Chojecki AL, et al. Among authors: avalos br. Leuk Lymphoma. 2022 Jun;63(6):1515-1517. doi: 10.1080/10428194.2022.2032037. Epub 2022 Feb 2. Leuk Lymphoma. 2022. PMID: 35105270 No abstract available.
76 results